<?xml version="1.0" encoding="UTF-8"?>
<p>Asthma is a chronic inflammatory disorder of the airways which has been regarded as a formidable challenge for clinicians. At present, the therapeutic effects of conventional medicine are still unsatisfactory [
 <xref rid="B84" ref-type="bibr">84</xref>]. Noteworthily, an in vivo study has indicated that an aqueous extract of FCB (200 mg/kg/three times/week for 56 days) could inhibit the development of asthma in mice by suppressing Th2 cytokines (IL-4, IL-5, and IL-13), IgE, histamine production, and reducing eosinophilic accumulation, as well as increasing of interferon-
 <italic>γ</italic> production [
 <xref rid="B67" ref-type="bibr">67</xref>] (
 <xref ref-type="fig" rid="fig9">Figure 9</xref>).
</p>
